Cerebral Ischemic Preconditioning: the Road So Far…

Area of Science:

• Neuroscience
• Cerebrovascular Research
• Molecular Biology

Background:

• Cerebral preconditioning involves the brain's adaptation to mild stressors, conferring temporary resistance to lethal ischemia.
• This phenomenon, well-studied in cardiac models, is increasingly recognized in the brain, offering potential neuroprotection.
• Ischemic stroke remains a major cause of death and disability worldwide, highlighting the need for effective treatments.

Purpose of the Study:

• To review current advancements in cerebral preconditioning research.
• To examine the molecular mechanisms underlying ischemic tolerance in the brain.
• To evaluate the clinical relevance and potential of various preconditioning strategies for stroke management.

Main Methods:

• Review of existing in vivo and in vitro studies on cerebral preconditioning.
• Analysis of molecular signaling pathways and biomolecules involved in inducing ischemic tolerance.
• Evaluation of different preconditioning stimuli, including remote ischemic and pharmacological approaches.

Main Results:

• Preconditioning activates diverse molecular machinery, leading to genomic reprogramming and a transient protective phenotype (ischemic tolerance).
• Various stimuli, such as hypoxia and anesthetics, can induce preconditioning by activating specific cellular pathways.
• Remote ischemic preconditioning and pharmacological preconditioning show promise for clinical application in stroke.

Conclusions:

• Cerebral preconditioning represents a promising avenue for neuroprotection against ischemic stroke.
• Translating experimental findings into clinical practice faces challenges but holds significant therapeutic potential.
• Further investigation into preconditioning agents is crucial for developing effective stroke management strategies.